LAMA5 pathogenic variant uncovers a novel autoantigen in membranous nephropathy.
A new autoantigen in membranous nephropathy was discovered, opening mechanistic insights for future research and therapy.
A pediatric case and mouse model implicated altered Laminin alpha-5 as a new autoantigen in membranous nephropathy. The mechanism is novel and relevant to an underserved condition, but one human case cannot establish prevalence or treatment efficacy.
What the study was
- Study design
- Single-patient genomic case study with knock-in mouse validation
- Population
- A child with severe membranous nephropathy and experimental knock-in mice
- Sample size
- 1
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Genes & diseases
Why it surfaced
The combined genetic, mechanistic, and animal evidence is unusually rich for a case report, but the single-patient basis requires conservative interpretation.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.